These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Drug delivery systems for topical ophthalmic medication. Halberg GP; Kelly SE; Morrone M Ann Ophthalmol; 1975 Sep; 7(9):1199-1204, 1207-9. PubMed ID: 1163927 [TBL] [Abstract][Full Text] [Related]
25. Influence of ophthalmic ointments on the penetration of pilocarpine drops. Ellis PP; Riegel M J Ocul Pharmacol; 1989; 5(2):119-25. PubMed ID: 2754296 [TBL] [Abstract][Full Text] [Related]
26. The effect of the low blink rate in rabbits on topical drug penetration. Maurice D J Ocul Pharmacol Ther; 1995; 11(3):297-304. PubMed ID: 8590262 [TBL] [Abstract][Full Text] [Related]
27. General Pharmacokinetic Model for Topically Administered Ocular Drug Dosage Forms. Deng F; Ranta VP; Kidron H; Urtti A Pharm Res; 2016 Nov; 33(11):2680-90. PubMed ID: 27431864 [TBL] [Abstract][Full Text] [Related]
28. Sulfobutyl ether beta-cyclodextrin (SBE-beta-CD) in eyedrops improves the tolerability of a topically applied pilocarpine prodrug in rabbits. Järvinen T; Järvinen K; Urtti A; Thompson D; Stella VJ J Ocul Pharmacol Ther; 1995; 11(2):95-106. PubMed ID: 8564640 [TBL] [Abstract][Full Text] [Related]
29. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 2: Precorneal retention and in vivo pharmacodynamic study. Rupenthal ID; Green CR; Alany RG Int J Pharm; 2011 Jun; 411(1-2):78-85. PubMed ID: 21453763 [TBL] [Abstract][Full Text] [Related]
30. Prolonged exposure to loteprednol etabonate in human tear fluid and rabbit ocular tissues following topical ocular administration of Lotemax gel, 0.5%. Glogowski S; Lowe E; Siou-Mermet R; Ong T; Richardson M J Ocul Pharmacol Ther; 2014 Feb; 30(1):66-73. PubMed ID: 24325539 [TBL] [Abstract][Full Text] [Related]
31. Sodium hyaluronate as an ophthalmic vehicle: some factors governing its effect on the ocular absorption of pilocarpine. Camber O; Edman P Curr Eye Res; 1989 Jun; 8(6):563-7. PubMed ID: 2743795 [TBL] [Abstract][Full Text] [Related]
32. Viscosity-dependent fluid dynamics of eyedrops on the ocular surface. Shimmura S; Goto E; Shimazaki J; Tsubota K Am J Ophthalmol; 1998 Mar; 125(3):386-8. PubMed ID: 9512158 [TBL] [Abstract][Full Text] [Related]
34. Ocular bioavailability and systemic loss of topically applied ophthalmic drugs. Patton TF; Francoeur M Am J Ophthalmol; 1978 Feb; 85(2):225-9. PubMed ID: 623195 [TBL] [Abstract][Full Text] [Related]
35. Prolonged, contemporaneous administration of pilocarpine and timolol increases the aqueous humor pilocarpine levels in rabbits. Burgalassi S; Chetoni P; Panichi L; Saettone MF J Ocul Pharmacol Ther; 1999 Feb; 15(1):1-7. PubMed ID: 10048342 [TBL] [Abstract][Full Text] [Related]
36. Effects on intraocular pressure and pupil size in glaucomatous beagles after topical pilocarpine instilled with standard (pH 5) and buffer-tip (pH 7) droptainers. Gelatt KN; Mackay EO; Gelatt JK; Stengard-Ollies K; Aza J J Ocul Pharmacol Ther; 1997 Apr; 13(2):95-104. PubMed ID: 9090610 [TBL] [Abstract][Full Text] [Related]
37. Toxicological evaluation of micafungin ophthalmic solution in rabbit eyes. Hiraoka T; Wakabayashi T; Kaji Y; Nanbu PN; Okamoto F; Kiuchi T; Fu B; Oshika T J Ocul Pharmacol Ther; 2005 Apr; 21(2):149-56. PubMed ID: 15857281 [TBL] [Abstract][Full Text] [Related]
38. Effect of pilocarpine ocular therapeutic systems on diurnal control of intraocular pressure. Fraunfelder FT; Shell JW; Herbst SF Ann Ophthalmol; 1976 Sep; 8(9):1031-9. PubMed ID: 970853 [TBL] [Abstract][Full Text] [Related]
39. Ocular penetration of pilocarpine: the effect on concentration on the ocular penetration of pilocarpine. Ramer RM; Gasset AR Ann Ophthalmol; 1974 Nov; 6(11):1160-2. PubMed ID: 4429321 [No Abstract] [Full Text] [Related]